Addus HomeCare Corporation (ADUS) Stock

Addus HomeCare Corporation (ADUS) is a Healthcare stock trading at $121.20 (as of 2026-08-25), with a market capitalization of $2.26B and a trailing P/E of 21.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Understand Addus HomeCare Corporation: how it makes money

Addus HomeCare provides non-medical personal care (bathing, dressing, meal prep) and hospice services to elderly and disabled Americans, billing Medicare, Medicaid, and private payers. The model is a labor arbitrage: most revenue is personal care billed per hour, and the entire profit depends on the spread between what insurers pay and what caregivers cost.

The profit engine is a labor spread: bill Medicare and private payers per hour, pay caregivers less, and pocket roughly 32% gross margin in between. When wages rise or fill rates drop, that spread compresses dollar for dollar.

Revenue by segment (latest quarter)
Personal Care$0.3B
Hospice$0.1B
Home Health$0.0B
Other$0.0B

Business quality (Mixed): Mixed: 8% revenue growth backed by a structurally aging U.S. demographic is defensible, but a 10% operating margin means any labor-cost shock or Medicare policy shift hits earnings with almost no cushion.

Valuation: At 21× earnings, ADUS trades 16% below the Healthcare Services average (25×).

Bull case

  • Hospice census breaking 4,000: Hospice census increased 6.5%, exceeding 4,000 patients in July, and same-store hospice growth ran at 19%. That is the fastest-growing segment in a company where the mix is shifting toward higher-value regulatory care.
  • Trading at a 16% discount: ADUS trades at a 21.4x P/E versus the Healthcare Services industry average of 25x, a 16% discount. For a business with 8% revenue growth and a defensive aging-demographic tailwind, that gap leaves room for re-rating if margins stabilize.
  • EMR integration cuts costs: Management flagged that the Gentiva EMR consolidation could generate approximately $1 million of annual synergies in 2027, a meaningful lever on a business where every dollar of cost hits the 10% operating line directly.

Bear case

  • Medicare cap hit hits hospice: Hospice incurred more than $3 million of Medicare cap accrual expense in the quarter, a regulatory charge that signals revenue-recognition risk whenever patient days push toward the cap limit. It is not a one-time item; it recurs as census grows.
  • Caregiver supply caps growth: Management identified caregiver availability as the primary constraint on personal-care organic growth. Until the labor market eases, the 70%-of-revenue Personal Care segment cannot scale at the pace the demographic would support.
  • Home health still shrinking: Home health remains in year-over-year revenue decline (the segment fell 7% YoY) despite sequential improvement. It is small at 5% of revenue, but it is the segment that is actively contracting, and Medicare payment policy remains a wildcard.
Valuation — source: SEC EDGAR (first-party)
Price$121.20
Market Cap$2.26B
P/E Ratio21.5
EV / EBITDA13.5
Price / Book1.97
Price / Sales1.53
FCF Yield6.8%
DCF Value (model)$77.69
DCF Upside vs Price-35.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.42B
Net Margin6.7%
Revenue Growth (YoY)8.0%
EPS Growth (YoY)23.8%
FCF Growth (YoY)81.8%
Financial Health — source: SEC EDGAR
Altman Z-Score5.69 (safe)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E21.5
Sector P/E (Healthcare)21.9
Industry P/E (Healthcare Services)25.4
vs Sector-2.1%
vs Industry-15.5%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($289.40M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOR. Dirk Allison
Employees6,165
CountryUS
IPO Date2009-10-28

Related Companies (Healthcare Services; 8 comparable companies)

  • Aveanna Healthcare Holdings Inc. (AVAH)
  • Chemed Corporation (CHE)
  • AdaptHealth Corp. (AHCO)
  • Option Care Health, Inc. (OPCH)
  • LifeStance Health Group, Inc. (LFST)
  • P3 Health Partners Inc. (PIII)
  • National HealthCare Corporation (NHC)
  • Progyny, Inc. (PGNY)
ADUS earnings history · ADUS institutional & insider holders · ADUS KPIs & operating metrics · ADUS financials · ADUS investor presentations & press releases · ADUS SEC filings · ADUS peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-25.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.